Study of the Combination of Panobinostat & Carfilzomib in Patients With Relapsed &/or Refractory Multiple Myeloma

NCT01549431 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Panobinostat
DRUG: Carfilzomib
DRUG: Dexamethasone

Sponsor

Emory University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]